Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities
2001 R44 PAR-99-101 CHEE, MARK S. ILLUMINA, INC. RANDOM ARRAYS FOR GENE EXPRESSION PROFILING Complete
2004 R44 PAR-01-106 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS Complete
2004 R44 PAR-01-105 BATTRELL, CHARLES FRED MICRONICS, INC. MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER Complete
2001 R44 PAR-99-101 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2001 R44 PAR-99-101 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2004 R44 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2009 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2006 U43 RFA-CA-06-006 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES Complete

Pages